FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Daniel Lindner

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Physiology

Procedures

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Shreeram Nallar; X Weihua; Sudhakar Kalakonda; Eric Lamarre; Daniel J Lindner; Robert R Lorenz; Dhan V Kalvakolanu
Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.
Daniel J Lindner; Ralph Tuthill; Yan Wu; John P Fruehauf; Rebecca Haney; Barbara S Jacobs; Ernest C Borden
Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis.
X Niu; Brian I Rini; Q Yan; L Liao; Daniel J Lindner; T Zhang; L Zhou; Ming Zhou; H Yang
The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Daniel Lindner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2013: Shreeram Nallar; X Weihua; Sudhakar Kalakonda; Eric Lamarre; Daniel J Lindner; Robert R Lorenz; Dhan V Kalvakolanu
Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.
The Journal of biological chemistry 2013;288(11):7930-41.
2013: Daniel J Lindner; Ralph Tuthill; Yan Wu; John P Fruehauf; Rebecca Haney; Barbara S Jacobs; Ernest C Borden
Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis.
Matrix biology : journal of the International Society for Matrix Biology 2013;32(2):123-32.
2012: X Niu; Brian I Rini; Q Yan; L Liao; Daniel J Lindner; T Zhang; L Zhou; Ming Zhou; H Yang
The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.
Oncogene 2012;31(6):776-86.
2011: Anita B Hjelmeland; Qiulian Wu; J M Heddleston; G S Choudhary; J MacSwords; Justin D Lathia; Roger E McLendon; Daniel J Lindner; A Sloan; Jeremy Rich
Acidic stress promotes a glioma stem cell phenotype.
Cell death and differentiation 2011;18(5):829-40.
2011: George S Hussey; Arindam Chaudhury; Andrea E Dawson; Daniel J Lindner; Charlotte R Knudsen; Matthew C J Wilce; William C Merrick; Philip H Howe
Identification of an mRNP complex regulating tumorigenesis at the translational elongation step.
Molecular cell 2011;41(4):419-31.
2010: ER Hofmann; Shreeram Nallar; Limei Lin; Jonathan D'Cunha; Daniel J Lindner; X Weihua; Dhan V Kalvakolanu
Identification and characterization of GRIM-1, a cell-death-associated gene product.
Journal of cell science 2010;123(Pt 16):2781-91.
2010: Suman Kundu; Keke Fan; Mingli Cao; Daniel J Lindner; Ralph Tuthill; Lili Liu; Stanton Gerson; Ernest Borden; Taolin Yi
Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeutics.
Molecular cancer therapeutics 2010;9(8):2287-96.
2010: Shreeram Nallar; Sudhakar Kalakonda; Peng Sun; Yoshihiro Ohmori; Miki Hiroi; Kazumasa Mori; Daniel J Lindner; Dhan V Kalvakolanu
Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activity.
The American journal of pathology 2010;177(2):896-907.
2010: Suman Kundu; Keke Fan; Mingli Cao; Daniel J Lindner; Zhizhaung Joe Zhao; Ernest Borden; Taolin Yi
Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(11):6529-36.
2010: Bon-Hun Koo; David M Coe; Laura J Dixon; Robert P T Somerville; Courtney M Nelson; Lauren W Wang; Mary Elizabeth Young; Daniel J Lindner; Suneel S Apte
ADAMTS9 is a cell-autonomously acting, anti-angiogenic metalloprotease expressed by microvascular endothelial cells.
The American journal of pathology 2010;176(3):1494-504.
2009: Bei H Morrison; R Haney; E Lamarre; Judith A Drazba; G D Prestwich; Daniel J Lindner
Gene deletion of inositol hexakisphosphate kinase 2 predisposes to aerodigestive tract carcinoma.
Oncogene 2009;28(25):2383-92.
2009: Daniel J Lindner; D Raghavan
Intra-tumoural extra-cellular pH: a useful parameter of response to chemotherapy in syngeneic tumour lines.
British journal of cancer 2009;100(8):1287-91.
2009: P Sun; Shreeram Nallar; Sudhakar Kalakonda; Daniel J Lindner; Stuart S Martin; Dhan V Kalvakolanu
GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuring.
Oncogene 2009;28(10):1339-47.
2008: Kevin L Taylor; Douglas W Leaman; Ron Grane; Nadir Mechti; Ernest C Borden; Daniel J Lindner
Identification of interferon-beta-stimulated genes that inhibit angiogenesis in vitro.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2008;28(12):733-40.
2008: Taolin Yi; Daniel J Lindner
The role and target potential of protein tyrosine phosphatases in cancer.
Current oncology reports 2008;10(2):114-21.
2007: Sudhakar Kalakonda; Shreeram Nallar; Ping Gong; Daniel J Lindner; Simeon E Goldblum; SEKHAR POTHIREDDY; Dhan V Kalvakolanu
Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.
The American journal of pathology 2007;171(4):1352-68.
2007: Shanjukumar Lisam; Michael Berk; Rhonda Oates; Zhenwen Zhao; Haiyan Tan; Ying Jiang; Aimin Zhou; Kashif Kirmani; Rosemary Steinmetz; Daniel J Lindner; Yan Xu
Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.
Journal of the National Cancer Institute 2007;99(17):1313-27.
2007: Jing Li; Daniel J Lindner; Carol Farver; Ernest C Borden; Taolin Yi
Efficacy of SSG and SSG/IFNalpha2 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG anti-tumor action.
Cancer chemotherapy and pharmacology 2007;60(3):341-9.
2007: Sudhakar Kalakonda; Shreeram Nallar; Daniel J Lindner; Jiadi Hu; SEKHAR POTHIREDDY; Dhan V Kalvakolanu
Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3.
Cancer research 2007;67(13):6212-20.
2007: Pavan Adiseshaiah; Daniel J Lindner; Dhan V Kalvakolanu; SEKHAR POTHIREDDY
FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo.
Cancer research 2007;67(13):6204-11.
2007: Bei H Morrison; John Anthony Bauer; Joseph A Lupica; Zhuo Tang; Heidi Schmidt; Joseph A DiDonato; Daniel J Lindner
Effect of inositol hexakisphosphate kinase 2 on transforming growth factor beta-activated kinase 1 and NF-kappaB activation.
The Journal of biological chemistry 2007;282(21):15349-56.
2007: Saubhik Sengupta; Kwan-Sik Kim; M P Berk; Rhonda K Oates; Pedro F Escobar; Jerome Belinson; W Li; Daniel J Lindner; B Williams; Yan Xu
Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
Oncogene 2007;26(20):2894-901.
2007: John Anthony Bauer; Joseph A Lupica; Heidi Schmidt; Bei H Morrison; Rebecca M Haney; Rhonda K Masci; Rebecca M Lee; Joseph A DiDonato; Daniel J Lindner
Nitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signaling.
PloS one 2007;2(12):e1313.
2006: Snehal G Thakkar; David M Peereboom; Thomas Olencki; Barbara Jacobs; Paul Elson; Lisa Rybicki; Daniel J Lindner; Ernest C Borden
Short communication: phase I clinical and gene modulatory evaluation of tamoxifen and IFN-alpha2b.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2006;26(11):800-3.
2006: Frederic J Reu; Soo In Bae; Leonid Cherkassky; Douglas W Leaman; Daniel J Lindner; Normand Beaulieu; A Robert MacLeod; Ernest C Borden
Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(23):3771-9.
2006: Zhuo Tang; John Anthony Bauer; Bei H Morrison; Daniel J Lindner
Nitrosylcobalamin promotes cell death via S nitrosylation of Apo2L/TRAIL receptor DR4.
Molecular and cellular biology 2006;26(15):5588-94.
2006: Kevin L Taylor; Rhonda K Oates; Ronald W Grane; Douglas W Leaman; Ernest C Borden; Daniel J Lindner
IFN-alpha1,8 inhibits tumor-induced angiogenesis in murine angiosarcomas.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2006;26(5):353-61.
2006: Jayashree M Paranjape; Da Xu; David M Kushner; James R Okicki; Daniel J Lindner; Hagen Cramer; Robert H Silverman; Douglas W Leaman
Human telomerase RNA degradation by 2'-5'-linked oligoadenylate antisense chimeras in a cell-free system, cultured tumor cells, and murine xenograft models.
Oligonucleotides 2006;16(3):225-38.
2006: Darren P Baker; Edward Y Lin; Kochung Lin; Maria Pellegrini; Russell C Petter; Ling Ling Chen; Robert M Arduini; Margot Brickelmaier; Dingyi Wen; Donna M Hess; Liqing Chen; Donna Grant; Adrian Whitty; Alan Gill; Daniel J Lindner; R Blake Pepinsky
N-terminally PEGylated human interferon-beta-1a with improved pharmacokinetic properties and in vivo efficacy in a melanoma angiogenesis model.
Bioconjugate chemistry 2006;17(1):179-88.
2005: Keke Fan; Ming Zhou; Manas K Pathak; Daniel J Lindner; Cengiz Z Altuntas; Vincent K Tuohy; Ernest C Borden; Taolin Yi
Sodium stibogluconate interacts with IL-2 in anti-Renca tumor action via a T cell-dependent mechanism in connection with induction of tumor-infiltrating macrophages.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(10):7003-8.
2005: Bei H Morrison; Zhuo Tang; Barbara S Jacobs; John Anthony Bauer; Daniel J Lindner
Apo2L/TRAIL induction and nuclear translocation of inositol hexakisphosphate kinase 2 during IFN-beta-induced apoptosis in ovarian carcinoma.
The Biochemical journal 2005;385(Pt 2):595-603.
2004: Mark M Whitmore; Michael J deVeer; Andrea Edling; Rhonda K Oates; Brenna Simons; Daniel J Lindner; Bryan R G Williams
Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity.
Cancer research 2004;64(16):5850-60.
2004: Mamta Chawla-Sarkar; Soo In Bae; Frederic J Reu; Barbara S Jacobs; Daniel J Lindner; Ernest C Borden
Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.
Cell death and differentiation 2004;11(8):915-23.
2004: Maurie Markman; Jerome Belinson; Kenneth Webster; Kristine Zanotti; Bei Morrison; Barbara Jacobs; Ernest C Borden; Daniel J Lindner
Phase 2 trial of interferon-beta as second-line treatment of ovarian cancer, fallopian tube cancer, or primary carcinoma of the peritoneum.
Oncology 2004;66(5):343-6.
2003: Mamta Chawla-Sarkar; John Anthony Bauer; Joseph A Lupica; Bei H Morrison; Zhuo Tang; Rhonda K Oates; alex almasan; Joseph A DiDonato; Ernest C Borden; Daniel J Lindner
Suppression of NF-kappa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL.
The Journal of biological chemistry 2003;278(41):39461-9.
2003: Mamta Chawla-Sarkar; Daniel J Lindner; Y-F Liu; B R Williams; G C Sen; R H Silverman; Ernest C Borden
Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis.
Apoptosis : an international journal on programmed cell death 2003;8(3):237-49.
2003: John Anthony Bauer; Bei H Morrison; Ronald W Grane; Barbara S Jacobs; Ernest C Borden; Daniel J Lindner
IFN-alpha2b and thalidomide synergistically inhibit tumor-induced angiogenesis.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2003;23(1):3-10.
2002: Manas K Pathak; Deepika Dhawan; Daniel J Lindner; Ernest C Borden; Carol Farver; Taolin Yi
Pentamidine is an inhibitor of PRL phosphatases with anticancer activity.
Molecular cancer therapeutics 2002;1(14):1255-64.
2002: Taolin Yi; Manas K Pathak; Daniel J Lindner; Michael E Ketterer; Carol Farver; Ernest C Borden
Anticancer activity of sodium stibogluconate in synergy with IFNs.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(10):5978-85.
2002: Daniel J Lindner
Interferons as antiangiogenic agents.
Current oncology reports 2002;4(6):510-4.
2002: Daniel J Lindner; Xinrong Ma; Jiadi Hu; Sreenivasu Karra; Dhan V Kalvakolanu
Thioredoxin reductase plays a critical role in IFN retinoid-mediated tumor-growth control in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(10):3210-8.
2002: John Anthony Bauer; Bei H Morrison; Ronald W Grane; Barbara S Jacobs; Sally Dabney; Ana M Gamero; Kevin Carnevale; Daniel J Smith; Judith A Drazba; Bellur Seetharam; Daniel J Lindner
Effects of interferon beta on transcobalamin II-receptor expression and antitumor activity of nitrosylcobalamin.
Journal of the National Cancer Institute 2002;94(13):1010-9.
2002: Xinrong Ma; Junbo Hu; Daniel J Lindner; Dhan V Kalvakolanu
Mutational analysis of human thioredoxin reductase 1. Effects on p53-mediated gene expression and interferon and retinoic acid-induced cell death.
The Journal of biological chemistry 2002;277(25):22460-8.
2002: Sanjit K Roy; Junbo Hu; Qingjun Meng; Ying Xia; Paul S. Shapiro; SEKHAR POTHIREDDY; Leonidas C Platanias; Daniel J Lindner; Peter F Johnson; Catrin Pritchard; Gilles Pagés; Jacques Pouyssegur; Dhan V Kalvakolanu
MEKK1 plays a critical role in activating the transcription factor C/EBP-beta-dependent gene expression in response to IFN-gamma.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(12):7945-50.
2002: Bei H Morrison; John Anthony Bauer; Jiadi Hu; Ronald W Grane; Aylin M Ozdemir; Mamta Chawla-Sarkar; Bendi Gong; alex almasan; Dhan V Kalvakolanu; Daniel J Lindner
Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics.
Oncogene 2002;21(12):1882-9.
2002: Victoria Y Gorbacheva; Daniel J Lindner; Ganes C Sen; Deborah J Vestal
The interferon (IFN)-induced GTPase, mGBP-2. Role in IFN-gamma-induced murine fibroblast proliferation.
The Journal of biological chemistry 2002;277(8):6080-7.
2001: Junbo Hu; Xinrong Ma; Daniel J Lindner; Sreenivasu Karra; ER Hofmann; SEKHAR POTHIREDDY; Dhan V Kalvakolanu
Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination.
Oncogene 2001;20(31):4235-48.
2001: Bei H Morrison; John Anthony Bauer; Dhan V Kalvakolanu; Daniel J Lindner
Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells.
The Journal of biological chemistry 2001;276(27):24965-70.
2001: Xinrong Ma; Sreenivasu Karra; W Guo; Daniel J Lindner; Junbo Hu; Jon E Angell; ER Hofmann; SEKHAR POTHIREDDY; Dhan V Kalvakolanu
Regulation of interferon and retinoic acid-induced cell death activation through thioredoxin reductase.
The Journal of biological chemistry 2001;276(27):24843-54.
2001: Xinrong Ma; Sreenivasu Karra; Daniel J Lindner; Junbo Hu; SEKHAR POTHIREDDY; A Kimchi; Junji Yodoi; Dhan V Kalvakolanu; D D Kalvakolanu
Thioredoxin participates in a cell death pathway induced by interferon and retinoid combination.
Oncogene 2001;20(28):3703-15.
2000: Jon E Angell; Daniel J Lindner; Paul S. Shapiro; ER Hofmann; Dhan V Kalvakolanu
Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach.
The Journal of biological chemistry 2000;275(43):33416-26.
2000: Daniel J Lindner; ER Hofmann; Sreenivasu Karra; Dhan V Kalvakolanu
The interferon-beta and tamoxifen combination induces apoptosis using thioredoxin reductase.
Biochimica et biophysica acta 2000;1496(2-3):196-206.
2000: Ernest C Borden; Daniel J Lindner; Robert Dreicer; M Hussein; David M Peereboom
Second-generation interferons for cancer: clinical targets.
Seminars in cancer biology 2000;10(2):125-44.
1999: Kutlan Ozker; BD Collier; Daniel J Lindner; Levent Kabasakal; Y Liu; Arthur Z Krasnow; Robert S Hellman; S D Edwards; C R Bourque; P D Crane
Biodistribution of 99Tcm-labelled 5-thio-D-glucose.
Nuclear medicine communications 1999;20(11):1055-8.
1998: ER Hofmann; M Boyanapalli; Daniel J Lindner; X Weihua; Bret A Hassel; R Jagus; Peter L Gutierrez; Dhan V Kalvakolanu; E R Hofman
Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid.
Molecular and cellular biology 1998;18(11):6493-504.
1998: X Weihua; S Ramanujam; Daniel J Lindner; R D Kudaravalli; R Freund; Dhan V Kalvakolanu
The polyoma virus T antigen interferes with interferon-inducible gene expression.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(3):1085-90.
1997: Daniel J Lindner; Ernest C Borden
Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1997;17(11):681-93.
1997: X Weihua; Daniel J Lindner; Dhan V Kalvakolanu
The interferon-inducible murine p48 (ISGF3gamma) gene is regulated by protooncogene c-myc.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(14):7227-32.
1997: Daniel J Lindner; Ernest C Borden; Dhan V Kalvakolanu
Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(6):931-7.
1997: Daniel J Lindner; Dhan V Kalvakolanu; Ernest C Borden
Increasing effectiveness of interferon-alpha for malignancies.
Seminars in oncology 1997;24(3 Suppl 9):S9-99-S9-104.
1997: Daniel J Lindner; Ernest C Borden
Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis.
International journal of cancer. Journal international du cancer 1997;71(3):456-61.
1997: Daniel J Lindner; V Kolla; Dhan V Kalvakolanu; Ernest C Borden
Tamoxifen enhances interferon-regulated gene expression in breast cancer cells.
Molecular and cellular biochemistry 1997;167(1-2):169-77.
1996: V Kolla; Daniel J Lindner; W Xiao; Ernest C Borden; Dhan V Kalvakolanu
Modulation of interferon (IFN)-inducible gene expression by retinoic acid. Up-regulation of STAT1 protein in IFN-unresponsive cells.
The Journal of biological chemistry 1996;271(18):10508-14.
1995: C L Sivinski; Daniel J Lindner; Ernest C Borden; Margaret A Tempero
Modulation of tumor-associated antigen expression on human pancreatic and prostate carcinoma cells in vitro by alpha- and gamma-interferons.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1995;18(3):156-65.
1982: Kenneth D Tew; A L Wang; Daniel J Lindner; P S Schein
Enhancement of nitrosourea cytotoxicity in vitro using hydrocortisone.
Biochemical pharmacology 1982;31(6):1179-80.
1980: Kenneth D Tew; P S Schein; Daniel J Lindner; A L Wang; M E Smulson
Influence of hydrocortisone on the binding of nitrosoureas to nuclear chromatin subfractions.
Cancer research 1980;40(10):3697-3703.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.